Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 1/2017

Open Access 01-12-2017 | Research article

Dose-response relationship between lower serum magnesium level and higher prevalence of knee chondrocalcinosis

Authors: Chao Zeng, Jie Wei, Robert Terkeltaub, Tuo Yang, Hyon K. Choi, Yi-lun Wang, Dong-xing Xie, David J. Hunter, Yuqing Zhang, Hui Li, Yang Cui, Liang-jun Li, Guang-hua Lei

Published in: Arthritis Research & Therapy | Issue 1/2017

Login to get access

Abstract

Background

The aim was to assess serum magnesium levels in relation to prevalence of knee chondrocalcinosis in two population-based Chinese studies.

Methods

Data included in this analysis consisted of two population-based cross-sectional studies, i.e., the Xiangya Hospital Health Management Center Study and the Xiangya Osteoarthritis (XO) Study I. A bilateral knee anteroposterior radiograph was obtained from each subject. Radiographic knee chondrocalcinosis was present if there was definite linear cartilage calcification. Serum magnesium concentration was measured using the chemiluminescence method. We examined the relation of serum magnesium levels to prevalence of knee chondrocalcinosis using generalized estimating equations.

Results

The prevalence of knee chondrocalcinosis was 1.4% in the Xiangya Hospital Health Management Center Study (n = 12,631). Compared with the lowest tertile, the age, sex and body mass index (BMI)-adjusted odds ratios (ORs) of chondrocalcinosis were 0.59 (95% CI 0.40–0.87) and 0.49 (95% CI 0.33–0.72) in the second and the third tertiles of serum magnesium, respectively (P for trend <0.001). The prevalence of knee chondrocalcinosis in the XO Study I (n = 1316) was 4.1%. The age, sex and BMI-adjusted ORs of chondrocalcinosis were 0.67 (95% CI 0.34–1.30) in the second and 0.45 (95% CI 0.21–0.94) in the third tertile of serum magnesium when compared with the lowest tertile (P for trend = 0.030). Similar results were observed in men and women in both studies. Adjusting for additional potential confounders did not change the results materially.

Conclusions

Subjects with lower levels of serum magnesium, even within the normal range, had higher prevalence of knee chondrocalcinosis in a dose-response relationship manner, suggesting that magnesium may have a preventive or therapeutic potential for knee chondrocalcinosis.
Appendix
Available only for authorised users
Literature
1.
Zhang W, Doherty M, Bardin T, Barskova V, Guerne PA, Jansen TL, Leeb BF, Perez-Ruiz F, Pimentao J, Punzi L, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011;70(4):563–70.CrossRefPubMed
2.
Fuerst M, Bertrand J, Lammers L, Dreier R, Echtermeyer F, Nitschke Y, Rutsch F, Schafer FK, Niggemeyer O, Steinhagen J, et al. Calcification of articular cartilage in human osteoarthritis. Arthritis Rheum. 2009;60(9):2694–703.CrossRefPubMed
3.
Nguyen C, Bazin D, Daudon M, Chatron-Colliet A, Hannouche D, Bianchi A, Come D, So A, Busso N, Busso N, et al. Revisiting spatial distribution and biochemical composition of calcium-containing crystals in human osteoarthritic articular cartilage. Arthritis Res Ther. 2013;15(5):R103.CrossRefPubMedPubMedCentral
4.
Rosenthal AK, Ryan LM. Calcium pyrophosphate deposition disease. N Engl J Med. 2016;374(26):2575–84.CrossRefPubMed
5.
Zhang Y, Terkeltaub R, Nevitt M, Xu L, Neogi T, Aliabadi P, Niu J, Felson DT. Lower prevalence of chondrocalcinosis in Chinese subjects in Beijing than in white subjects in the United States: The Beijing Osteoarthritis Study. Arthritis Rheum. 2006;54(11):3508–12.CrossRefPubMed
6.
Richette P, Ayoub G, Lahalle S, Vicaut E, Badran A, Joly F, Messing B, Bardin T. Hypomagnesemia associated with chondrocalcinosis: a cross-sectional study. Arthritis Rheum. 2007;57(8):1496–501.CrossRefPubMed
7.
Ellman MH. Images in clinical medicine. Chondrocalcinosis and hypomagnesemia. N Engl J Med. 2009;360(1):71.CrossRefPubMed
8.
Milazzo SC, Ahern MJ, Cleland LG, Henderson DR. Calcium pyrophosphate dihydrate deposition disease and familial hypomagnesemia. J Rheumatol. 1981;8(5):767–71.PubMed
9.
Smilde TJ, Haverman JF, Schipper P, Hermus AR, van Liebergen FJ, Jansen JL, Kloppenborg PW, Koolen MI. Familial hypokalemia/hypomagnesemia and chondrocalcinosis. J Rheumatol. 1994;21(8):1515–9.PubMed
10.
Richette P, Ayoub G, Bardin T, Bouvet S, Orcel P, Badran AM. Hypomagnesemia and chondrocalcinosis in short bowel syndrome. J Rheumatol. 2005;32(12):2434–6.PubMed
11.
Ea HK, Blanchard A, Dougados M, Roux C. Chondrocalcinosis secondary to hypomagnesemia in Gitelman's syndrome. J Rheumatol. 2005;32(9):1840–2.PubMed
12.
Zeng C, Wei J, Li H, Yang T, Zhang FJ, Pan D, Xiao YB, Yang TB, Lei GH. Relationship between serum magnesium concentration and radiographic knee osteoarthritis. J Rheumatol. 2015;42(7):1231–6.CrossRefPubMed
13.
Li H, Zeng C, Wei J, Yang T, Gao SG, Luo W, Li YS, Xiong YL, Xiao WF, Lei GH. Associations of dietary and serum magnesium with serum high-sensitivity C-reactive protein in early radiographic knee osteoarthritis patients. Mod Rheumatol. 2017;27(4):669–74.CrossRefPubMed
14.
Zeng C, Wang YL, Wei J, Yang T, Li H, Xie DX, Li YS, Lei GH. Association between low serum magnesium concentration and hyperuricemia. Magnes Res. 2015;28(2):56–63.PubMed
15.
16.
17.
Abhishek A, Doherty S, Maciewicz R, Muir K, Zhang W, Doherty M. Chondrocalcinosis is common in the absence of knee involvement. Arthritis Res Ther. 2012;14(5):R205.CrossRefPubMedPubMedCentral
18.
Zhang Y, Glynn RJ, Felson DT. Musculoskeletal disease research: should we analyze the joint or the person? J Rheumatol. 1996;23(7):1130.PubMed
19.
Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. N Engl J Med. 1995;333(21):1369–73.CrossRefPubMed
20.
Schöttker B, Herder C, Rothenbacher D, Perna L, Müller H, Brenner H. Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults. Eur J Epidemiol. 2013;28(3):267–75.CrossRefPubMed
21.
Britton WM, Stokstad EL. Aorta and other soft tissue calcification in the magnesium-deficient rat. J Nutr. 1970;100(12):1501–5.PubMed
22.
Planells E, Llopis J, Peran F, Aranda P. Changes in tissue calcium and phosphorus content and plasma concentrations of parathyroid hormone and calcitonin after long-term magnesium deficiency in rats. J Am Coll Nutr. 1995;14(3):292–8.CrossRefPubMed
23.
Altura BT, Brust M, Bloom S, Barbour RL, Stempak JG, Altura BM. Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci U S A. 1990;87(5):1840–4.CrossRefPubMedPubMedCentral
24.
King JL, Miller RJ, Blue JP, O'Brien WD, Erdman JW. Inadequate dietary magnesium intake increases atherosclerotic plaque development in rabbits. Nutr Res. 2009;29(5):343–9.CrossRefPubMedPubMedCentral
25.
Doherty M, Dieppe P. Double blind, placebo controlled trial of magnesium carbonate in chronic pyrophosphate arthropathy. Ann Rheum Dis. 1983;42 Suppl 1:106.CrossRefPubMedCentral
26.
Tramer MR, Schneider J, Marti RA, Rifat K. Role of magnesium sulfate in postoperative analgesia. Anesthesiology. 1996;84(2):340–7.CrossRefPubMed
27.
Massy ZA, Drueke TB. Magnesium and cardiovascular complications of chronic kidney disease. Nat Rev Nephrol. 2015;11(7):432–42.CrossRefPubMed
28.
Cheng PT, Grabher JJ, LeGeros RZ. Effects of magnesium on calcium phosphate formation. Magnesium. 1988;7(3):123–32.PubMed
29.
Lagier R, Baud CA. Magnesium whitlockite, a calcium phosphate crystal of special interest in pathology. Pathol Res Pract. 2003;199(5):329–35.CrossRefPubMed
30.
Louvet L, Buchel J, Steppan S, Passlick-Deetjen J, Massy ZA. Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant. 2013;28(4):869–78.CrossRefPubMed
31.
Kircelli F, Peter ME, Sevinc Ok E, Celenk FG, Yilmaz M, Steppan S, Asci G, Ok E, Passlick-Deetjen J. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant. 2012;27(2):514–21.CrossRefPubMed
32.
Montezano AC, Zimmerman D, Yusuf H, Burger D, Chignalia AZ, Wadhera V, van Leeuwen FN, Touyz RM. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension. 2010;56(3):453–62.CrossRefPubMed
33.
De Schutter TM, Behets GJ, Geryl H, Peter ME, Steppan S, Gundlach K, Passlick-Deetjen J, D'Haese PC, Neven E. Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia. Kidney Int. 2013;83(6):1109–17.CrossRefPubMedPubMedCentral
34.
Henaut L, Boudot C, Massy ZA, Lopez-Fernandez I, Dupont S, Mary A, Drueke TB, Kamel S, Brazier M, Mentaverri R. Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action. Cardiovasc Res. 2014;101(2):256–65.CrossRefPubMed
35.
Ivanovski O, Nikolov IG, Joki N, Caudrillier A, Phan O, Mentaverri R, Maizel J, Hamada Y, Nguyen-Khoa T, Fukagawa M, et al. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE−/−) mice. Atherosclerosis. 2009;205(1):55–62.CrossRefPubMed
36.
Rodriguez-Ortiz ME, Canalejo A, Herencia C, Martinez-Moreno JM, Peralta-Ramirez A, Perez-Martinez P, Navarro-Gonzalez JF, Rodriguez M, Peter M, Gundlach K, et al. Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration. Nephrol Dial Transplant. 2014;29(2):282–9.CrossRefPubMed
37.
Altura BM, Altura BT, Carella A, Gebrewold A, Murakawa T, Nishio A. Mg2 + -Ca2+ interaction in contractility of vascular smooth muscle: Mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels. Can J Physiol Pharmacol. 1987;65(4):729–45.CrossRefPubMed
38.
Zhang J, Berra-Romani R, Sinnegger-Brauns MJ, Striessnig J, Blaustein MP, Matteson DR. Role of Cav1.2 L-type Ca2+ channels in vascular tone: effects of nifedipine and Mg2+. AJP Heart Circ Physiol. 2006;292(1):H415–25.CrossRef
39.
Liamis G, Rodenburg EM, Hofman A, Zietse R, Stricker BH, Hoorn EJ. Electrolyte disorders in community subjects: prevalence and risk factors. Am J Med. 2013;126(3):256–63.CrossRefPubMed
40.
Peacock JM, Folsom AR, Arnett DK, Eckfeldt JH, Szklo M. Relationship of serum and dietary magnesium to incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol. 1999;9(3):159–65.CrossRefPubMed
41.
Akizawa Y, Koizumi S, Itokawa Y, Ojima T, Nakamura Y, Tamura T, Kusaka Y. Daily magnesium intake and serum magnesium concentration among Japanese people. J Epidemiol. 2008;18(4):151–9.CrossRefPubMedPubMedCentral
42.
Abhishek A, Doherty S, Maciewicz RA, Muir K, Zhang W, Doherty M. Does chondrocalcinosis associate with a distinct radiographic phenotype of osteoarthritis in knees and hips? A case-control study. Arthritis Care Res. 2016;68(2):211–6.CrossRef
43.
VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167(4):268–74.CrossRefPubMed
44.
Zeng C, Li Y, Wei J, Xie D, Xie X, Li L, Gao S, Luo W, Xiong Y, Xiao W, et al. Analgesic effect and safety of single-dose intra-articular magnesium after arthroscopic surgery: a systematic review and meta-analysis. Sci Rep-Uk. 2016;6:38024.CrossRef
45.
Hunter DJ. Evidence of altered bone turnover, vitamin D and calcium regulation with knee osteoarthritis in female twins. Rheumatology. 2003;42(11):1311–6.CrossRefPubMed
46.
Felson DT. The epidemiology of knee osteoarthritis: results from the Framingham Osteoarthritis Study. Semin Arthritis Rheum. 1990;20(3 Suppl 1):42–50.CrossRefPubMed
47.
Ledingham J, Dawson S, Preston B, Milligan G, Doherty M. Radiographic patterns and associations of osteoarthritis of the hip. Ann Rheum Dis. 1992;51(10):1111–6.CrossRefPubMedPubMedCentral
48.
Ledingham J, Regan M, Jones A, Doherty M. Radiographic patterns and associations of osteoarthritis of the knee in patients referred to hospital. Ann Rheum Dis. 1993;52(7):520–6.CrossRefPubMedPubMedCentral
49.
Sanmarti R, Kanterewicz E, Pladevall M, Panella D, Tarradellas JB, Gomez JM. Analysis of the association between chondrocalcinosis and osteoarthritis: a community based study. Ann Rheum Dis. 1996;55(1):30–3.CrossRefPubMedPubMedCentral
50.
Neame RL, Carr AJ, Muir K, Doherty M. UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis. 2003;62(6):513–8.CrossRefPubMedPubMedCentral
51.
Musacchio E, Ramonda R, Perissinotto E, Sartori L, Hirsch R, Punzi L, Zambon S, Corti M, Baggio G, Manzato E, et al. The impact of knee and hip chondrocalcinosis on disability in older people: the ProVA Study from northeastern Italy. Ann Rheum Dis. 2011;70(11):1937–43.CrossRefPubMed
52.
Abhishek A, Doherty S, Maciewicz R, Muir K, Zhang W, Doherty M. Evidence of a systemic predisposition to chondrocalcinosis and association between chondrocalcinosis and osteoarthritis at distant joints: a cross-sectional study. Arthritis Care Res. 2013;65(7):1052–8.CrossRef
Metadata
Title
Dose-response relationship between lower serum magnesium level and higher prevalence of knee chondrocalcinosis
Authors
Chao Zeng
Jie Wei
Robert Terkeltaub
Tuo Yang
Hyon K. Choi
Yi-lun Wang
Dong-xing Xie
David J. Hunter
Yuqing Zhang
Hui Li
Yang Cui
Liang-jun Li
Guang-hua Lei
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2017
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-017-1450-6

Other articles of this Issue 1/2017

Arthritis Research & Therapy 1/2017 Go to the issue

Research article

RANK/RANKL/OPG system in the intervertebral disc

Research article

Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year

Research article

Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis

Research article

Ultrasound verified inflammation and structural damage in patients with hereditary haemochromatosis-related arthropathy

Research article

Ultrasonography and dual-energy computed tomography provide different quantification of urate burden in gout: results from a cross-sectional study

Research article

Identification of potential saliva and tear biomarkers in primary Sjögren’s syndrome, utilising the extraction of extracellular vesicles and proteomics analysis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits